Mitogen-Activated Protein Kinase 3 Human Recombinant, MAPK3 Human, 10ug
Mitogen-Activated Protein Kinase 3 Human Recombinant, MAPK3 Human, 10ug
| CAT No.BT-PKA-213 |
| Mitogen-Activated Protein Kinase 3 Human Recombinant, MAPK3 Human, 10ug |
Description
ERK1/MAPK3 Recombinant is a highly active form produced by phosphorylation of the purified ERK1/MAPK3 in vitro with MEK1 is a non-glycosylated polypeptide having a molecular mass of 43.6 kDa.
ERK1/MAPK3 is purified by proprietary chromatographic techniques.
Formulation
ERK1 is supplied as 2.6mg/ml containing 50mM Tris-HCL, 150mM NaCl, 2mM DTT, 5mM EDTA, pH 8.0.
Physical Appearance
Sterile Filtered clear solution.
Source
Escherichia Coli.
Storage Conditions
Store at 4¡ãC if entire vial will be used within 2-4 weeks.
Store, frozen at -20¡ãC for longer periods of time.
Avoid multiple freeze-thaw cycles.
Synonyms
Mitogen-activated protein kinase 3, EC 2.7.11.24, Extracellular signal-regulated kinase 1, ERK-1, Insulin-stimulated MAP2 kinase, MAP kinase 1, MAPK 1, p44-ERK1, ERT2, p44-MAPK, Microtubule-associated protein 2 kinase, ERK1, PRKM3, P44ERK1, P44MAPK, HS44KDAP, HUMKER1A, MGC20180.
Unit Definition
No protease activity detectable, specific activity > 200 U*/mg
(*1 U = 1 pmol/min transferred to myelin basic protein at 30 degree C).
Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Product features
Product features
Materials and care
Materials and care
Merchandising tips
Merchandising tips
Share
